Palvella Therapeutics (PVLA) PT Raised to $241 at Lucid Capital Markets
Tweet Send to a Friend
Lucid Capital Markets analyst Dev Prasad raised the price target on Palvella Therapeutics (NASDAQ: PVLA) to $241.00 (from $212.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
